CYTOCARE 532

Product Description

CYTOCARE 532 is an advanced mesotherapy solution designed for comprehensive skin rejuvenation. This innovative product combines 32mg of non-cross-linked hyaluronic acid with the proprietary CT50 rejuvenating complex, delivering essential nutrients directly to the superficial dermis. Manufactured by Laboratoires Revitacare, this professional-grade treatment addresses multiple signs of aging while promoting optimal skin regeneration.

Each package contains 10 vials of 5ml, providing healthcare professionals with a reliable supply for multiple patient treatments. The formulation’s unique composition makes it particularly effective for addressing fine lines, improving skin hydration, and restoring radiance in patients with mild to moderate skin aging concerns.

CYTOCARE 532 Dosage and Administration

Administration of CYTOCARE 532 requires proper technique and adherence to established protocols. Healthcare professionals should use sterile 30-G needles for each injection area, ensuring even pressure throughout the procedure. The product should be injected slowly into the middle or superficial dermis, followed by gentle massage to evenly distribute the solution.

Recommended treatment protocols include three initial sessions at three-week intervals, followed by maintenance treatments every three months. Various injection techniques can be employed, including cross-hatching, point-by-point, retro-tracing, and fan patterns, depending on the treatment area and patient needs.

Ingredient Information

CYTOCARE 532 contains a sophisticated blend of active ingredients designed to support comprehensive skin rejuvenation. Each 5 ml vial contains 32mg of non-cross-linked hyaluronic acid, providing immediate hydration and volume restoration.

The CT50 rejuvenating complex includes essential vitamins (retinol, thiamin, riboflavin, nicotinamide, dexpanthenol, pyridoxine, ascorbic acid, ergocalciferol, and tocopherol), 20 amino acids, and vital microelements. 

Storage Instructions

Proper storage of CYTOCARE products ensures optimal efficacy and safety. The vials should be stored at room temperature between 2°C and 30°C, protected from direct light and freezing temperatures. Healthcare facilities should maintain suitable storage conditions to preserve the integrity of hyaluronic acid and other active ingredients.

CYTOCARE 532 Contraindications

CYTOCARE 532 should not be used in patients with known hypersensitivity to any component of the formulation. The treatment is contraindicated in patients with active skin infections, inflammatory conditions, or autoimmune disorders affecting the treatment area. Pregnant and breastfeeding women should avoid this product.

CYTOCARE 532 Precautions and Warnings

Before administering CYTOCARE 532, practitioners should conduct thorough patient assessments and obtain informed consent. Patients should avoid high-dose aspirin for one week before injection to minimize the risk. Post-treatment care includes avoiding cosmetics for 12 hours and protecting treated areas from extreme temperatures.

CYTOCARE 532 Manufacturer and Regulatory Information

CYTOCARE 532 is manufactured by Laboratoires Revitacare, a French pharmaceutical company specializing in aesthetic medicine and cosmetology products. The product holds CE certification, meeting stringent European quality and safety standards. Manufacturing follows GMP and ISO 13485 guidelines, ensuring consistent quality and reliability.

Healthcare professionals can order CYTOCARE through authorized distributors, ensuring product authenticity and proper handling throughout the supply chain. Regular quality control measures and batch tracking maintain the highest standards for this professional-grade dermal solution.